Clinical Researcher—February 2019 (Volume 33, Issue 2) CHAIR’S MESSAGE John P. Neal, CRCP We’ve had a strong start out of the gate for 2019, and the year ahead […]
Clinical Researcher—February 2019 (Volume 33, Issue 2) SCIENCE & SOCIETY Daniel Kavanagh, PhD This article will provide a brief overview of the state of genome-editing technologies as […]
A spate of late 2018 U.S. Food and Drug Administration guidances on gene therapy has significantly changed the 2019 clinical trial landscape, warns Meagan Vaughn, PhD, RAC, a research scientist […]
Tracking key operational indicators such as site activation, enrollment, and monitoring targets can help identify problems in clinical trial projects while they are still relatively tiny and manageable, says Cynthia […]
Study sites that fail to conduct adequate billing coverage analysis are “leaving money on the table,” says Kelly Willenberg, owner of Kelly Willenberg LLC. “We see people who don’t do […]